<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Yang X</submitter><pubmed_abstract>Aberrant expression of circRNAs has been proven to play a crucial role in the progression of acute myeloid leukemia (AML); however, its regulatory mechanism remains unclear. Herein, we identified a novel circRNA, Circ_0001187, which is downregulated in AML patients, and its low level contributes to a poor prognosis. We further validated their expression in large-scale samples and found that only the expression of Circ_0001187 was significantly decreased in newly diagnosed (ND) AML patients and increased in patients with hematological complete remission (HCR) compared with controls. Knockdown of Circ_0001187 significantly promoted proliferation and inhibited apoptosis of AML cells in vitro and in vivo, whereas overexpression of Circ _0001187 exerted the opposite effects. Interestingly, we f</pubmed_abstract><journal>Biomarker research</journal><pagination>59</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10243067</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.</pubmed_title><pmcid>PMC10243067</pmcid><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Ji C</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Hu X</pubmed_authors><pubmed_authors>Jia W</pubmed_authors><pubmed_authors>Ma D</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Can C</pubmed_authors><pubmed_authors>Han F</pubmed_authors><pubmed_authors>Wu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.</name><description>Aberrant expression of circRNAs has been proven to play a crucial role in the progression of acute myeloid leukemia (AML); however, its regulatory mechanism remains unclear. Herein, we identified a novel circRNA, Circ_0001187, which is downregulated in AML patients, and its low level contributes to a poor prognosis. We further validated their expression in large-scale samples and found that only the expression of Circ_0001187 was significantly decreased in newly diagnosed (ND) AML patients and increased in patients with hematological complete remission (HCR) compared with controls. Knockdown of Circ_0001187 significantly promoted proliferation and inhibited apoptosis of AML cells in vitro and in vivo, whereas overexpression of Circ _0001187 exerted the opposite effects. Interestingly, we f</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2026-05-28T19:42:21.519Z</modification><creation>2025-04-06T14:08:04.73Z</creation></dates><accession>S-EPMC10243067</accession><cross_references><pubmed>37280654</pubmed><doi>10.1186/s40364-023-00495-4</doi></cross_references></HashMap>